ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Night Blindness Treatment Market Research Report 2025
Published Date: March 2025
|
Report Code: QYRE-Auto-27C10045
Home | Market Reports | People & Society
Global Night Blindness Treatment Market Research Report 2022
BUY CHAPTERS

Global Night Blindness Treatment Market Research Report 2025

Code: QYRE-Auto-27C10045
Report
March 2025
Pages:91
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Merck
Pfizer Inc
GlaxoSmithKline PLC
Johnson & Johnson Private Limited
Roche Holding AG
Abbott
Mylan NV
Teva Pharmaceuticals
Sanofi
Novartis
Bayer
Sun Pharmaceutical Industries
Aurobindo Pharma
Lupin Pharma
Sumitomo Dainippon Pharma
LEO Pharma
Bausch Health
Astrazeneca plc
Cipla Ltd
Eli Lilly

Night Blindness Treatment Market Size

The global market for Night Blindness Treatment was valued at US$ 15.6 million in the year 2024 and is projected to reach a revised size of US$ 19.9 million by 2031, growing at a CAGR of 3.6% during the forecast period.

Night Blindness Treatment Market

Night Blindness Treatment Market

Night blindness, is a disorder in which your eyes are unable to adjust to low light circumstances. Night blindness is most commonly caused by abnormalities with your rod cells, but it can also be caused by a variety of other factors. Night blindness affects people"s ability to see in dimly lit areas or at night. The treatment for night blindness is entirely dependent on the underlying reason. It is caused by a variety of illnesses that cause the retina"s rods to degenerate. It is also termed as nyctalopia. This condition is characterized by eye pain vomiting, cloudy vision, halos, light sensitivity, distance vision problem, and headache.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Night Blindness Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Night Blindness Treatment.
The Night Blindness Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Night Blindness Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Night Blindness Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Night Blindness Treatment Market Report

Report Metric Details
Report Name Night Blindness Treatment Market
Accounted market size in year US$ 15.6 million
Forecasted market size in 2031 US$ 19.9 million
CAGR 3.6%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Clinic
  • Hospital
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Merck, Pfizer, GlaxoSmithKline, Johnson & Johnson Private Limited, Roche Holding AG, Abbott, Mylan, Teva Pharmaceuticals, Sanofi, Novartis, Bayer, Sun Pharmaceutical Industries, Aurobindo Pharma, Lupin pharma, Eli Lilly, Sumitomo Dainippon Pharma, Leo Pharma, Bausch Health, AstraZeneca, Cipla
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Night Blindness Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Night Blindness Treatment Market growing?

Ans: The Night Blindness Treatment Market witnessing a CAGR of 3.6% during the forecast period 2025-2031.

What is the Night Blindness Treatment Market size in 2031?

Ans: The Night Blindness Treatment Market size in 2031 will be US$ 19.9 million.

Who are the main players in the Night Blindness Treatment Market report?

Ans: The main players in the Night Blindness Treatment Market are Merck, Pfizer, GlaxoSmithKline, Johnson & Johnson Private Limited, Roche Holding AG, Abbott, Mylan, Teva Pharmaceuticals, Sanofi, Novartis, Bayer, Sun Pharmaceutical Industries, Aurobindo Pharma, Lupin pharma, Eli Lilly, Sumitomo Dainippon Pharma, Leo Pharma, Bausch Health, AstraZeneca, Cipla

What are the Application segmentation covered in the Night Blindness Treatment Market report?

Ans: The Applications covered in the Night Blindness Treatment Market report are Clinic, Hospital

What are the Type segmentation covered in the Night Blindness Treatment Market report?

Ans: The Types covered in the Night Blindness Treatment Market report are Vitamin AD Drops, Vitamin AD Softgels, Vitamin A Capsule

Recommended Reports

Ophthalmic Treatments

Eye Drug Delivery

Vision Disorders

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Night Blindness Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Vitamin AD Drops
1.2.3 Vitamin AD Softgels
1.2.4 Vitamin A Capsule
1.3 Market by Application
1.3.1 Global Night Blindness Treatment Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Clinic
1.3.3 Hospital
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Night Blindness Treatment Market Perspective (2020-2031)
2.2 Global Night Blindness Treatment Growth Trends by Region
2.2.1 Global Night Blindness Treatment Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Night Blindness Treatment Historic Market Size by Region (2020-2025)
2.2.3 Night Blindness Treatment Forecasted Market Size by Region (2026-2031)
2.3 Night Blindness Treatment Market Dynamics
2.3.1 Night Blindness Treatment Industry Trends
2.3.2 Night Blindness Treatment Market Drivers
2.3.3 Night Blindness Treatment Market Challenges
2.3.4 Night Blindness Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Night Blindness Treatment Players by Revenue
3.1.1 Global Top Night Blindness Treatment Players by Revenue (2020-2025)
3.1.2 Global Night Blindness Treatment Revenue Market Share by Players (2020-2025)
3.2 Global Night Blindness Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Night Blindness Treatment Revenue
3.4 Global Night Blindness Treatment Market Concentration Ratio
3.4.1 Global Night Blindness Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Night Blindness Treatment Revenue in 2024
3.5 Global Key Players of Night Blindness Treatment Head office and Area Served
3.6 Global Key Players of Night Blindness Treatment, Product and Application
3.7 Global Key Players of Night Blindness Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Night Blindness Treatment Breakdown Data by Type
4.1 Global Night Blindness Treatment Historic Market Size by Type (2020-2025)
4.2 Global Night Blindness Treatment Forecasted Market Size by Type (2026-2031)
5 Night Blindness Treatment Breakdown Data by Application
5.1 Global Night Blindness Treatment Historic Market Size by Application (2020-2025)
5.2 Global Night Blindness Treatment Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Night Blindness Treatment Market Size (2020-2031)
6.2 North America Night Blindness Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Night Blindness Treatment Market Size by Country (2020-2025)
6.4 North America Night Blindness Treatment Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Night Blindness Treatment Market Size (2020-2031)
7.2 Europe Night Blindness Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Night Blindness Treatment Market Size by Country (2020-2025)
7.4 Europe Night Blindness Treatment Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Night Blindness Treatment Market Size (2020-2031)
8.2 Asia-Pacific Night Blindness Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Night Blindness Treatment Market Size by Region (2020-2025)
8.4 Asia-Pacific Night Blindness Treatment Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Night Blindness Treatment Market Size (2020-2031)
9.2 Latin America Night Blindness Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Night Blindness Treatment Market Size by Country (2020-2025)
9.4 Latin America Night Blindness Treatment Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Night Blindness Treatment Market Size (2020-2031)
10.2 Middle East & Africa Night Blindness Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Night Blindness Treatment Market Size by Country (2020-2025)
10.4 Middle East & Africa Night Blindness Treatment Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Merck
11.1.1 Merck Company Details
11.1.2 Merck Business Overview
11.1.3 Merck Night Blindness Treatment Introduction
11.1.4 Merck Revenue in Night Blindness Treatment Business (2020-2025)
11.1.5 Merck Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Night Blindness Treatment Introduction
11.2.4 Pfizer Revenue in Night Blindness Treatment Business (2020-2025)
11.2.5 Pfizer Recent Development
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Company Details
11.3.2 GlaxoSmithKline Business Overview
11.3.3 GlaxoSmithKline Night Blindness Treatment Introduction
11.3.4 GlaxoSmithKline Revenue in Night Blindness Treatment Business (2020-2025)
11.3.5 GlaxoSmithKline Recent Development
11.4 Johnson & Johnson Private Limited
11.4.1 Johnson & Johnson Private Limited Company Details
11.4.2 Johnson & Johnson Private Limited Business Overview
11.4.3 Johnson & Johnson Private Limited Night Blindness Treatment Introduction
11.4.4 Johnson & Johnson Private Limited Revenue in Night Blindness Treatment Business (2020-2025)
11.4.5 Johnson & Johnson Private Limited Recent Development
11.5 Roche Holding AG
11.5.1 Roche Holding AG Company Details
11.5.2 Roche Holding AG Business Overview
11.5.3 Roche Holding AG Night Blindness Treatment Introduction
11.5.4 Roche Holding AG Revenue in Night Blindness Treatment Business (2020-2025)
11.5.5 Roche Holding AG Recent Development
11.6 Abbott
11.6.1 Abbott Company Details
11.6.2 Abbott Business Overview
11.6.3 Abbott Night Blindness Treatment Introduction
11.6.4 Abbott Revenue in Night Blindness Treatment Business (2020-2025)
11.6.5 Abbott Recent Development
11.7 Mylan
11.7.1 Mylan Company Details
11.7.2 Mylan Business Overview
11.7.3 Mylan Night Blindness Treatment Introduction
11.7.4 Mylan Revenue in Night Blindness Treatment Business (2020-2025)
11.7.5 Mylan Recent Development
11.8 Teva Pharmaceuticals
11.8.1 Teva Pharmaceuticals Company Details
11.8.2 Teva Pharmaceuticals Business Overview
11.8.3 Teva Pharmaceuticals Night Blindness Treatment Introduction
11.8.4 Teva Pharmaceuticals Revenue in Night Blindness Treatment Business (2020-2025)
11.8.5 Teva Pharmaceuticals Recent Development
11.9 Sanofi
11.9.1 Sanofi Company Details
11.9.2 Sanofi Business Overview
11.9.3 Sanofi Night Blindness Treatment Introduction
11.9.4 Sanofi Revenue in Night Blindness Treatment Business (2020-2025)
11.9.5 Sanofi Recent Development
11.10 Novartis
11.10.1 Novartis Company Details
11.10.2 Novartis Business Overview
11.10.3 Novartis Night Blindness Treatment Introduction
11.10.4 Novartis Revenue in Night Blindness Treatment Business (2020-2025)
11.10.5 Novartis Recent Development
11.11 Bayer
11.11.1 Bayer Company Details
11.11.2 Bayer Business Overview
11.11.3 Bayer Night Blindness Treatment Introduction
11.11.4 Bayer Revenue in Night Blindness Treatment Business (2020-2025)
11.11.5 Bayer Recent Development
11.12 Sun Pharmaceutical Industries
11.12.1 Sun Pharmaceutical Industries Company Details
11.12.2 Sun Pharmaceutical Industries Business Overview
11.12.3 Sun Pharmaceutical Industries Night Blindness Treatment Introduction
11.12.4 Sun Pharmaceutical Industries Revenue in Night Blindness Treatment Business (2020-2025)
11.12.5 Sun Pharmaceutical Industries Recent Development
11.13 Aurobindo Pharma
11.13.1 Aurobindo Pharma Company Details
11.13.2 Aurobindo Pharma Business Overview
11.13.3 Aurobindo Pharma Night Blindness Treatment Introduction
11.13.4 Aurobindo Pharma Revenue in Night Blindness Treatment Business (2020-2025)
11.13.5 Aurobindo Pharma Recent Development
11.14 Lupin pharma
11.14.1 Lupin pharma Company Details
11.14.2 Lupin pharma Business Overview
11.14.3 Lupin pharma Night Blindness Treatment Introduction
11.14.4 Lupin pharma Revenue in Night Blindness Treatment Business (2020-2025)
11.14.5 Lupin pharma Recent Development
11.15 Eli Lilly
11.15.1 Eli Lilly Company Details
11.15.2 Eli Lilly Business Overview
11.15.3 Eli Lilly Night Blindness Treatment Introduction
11.15.4 Eli Lilly Revenue in Night Blindness Treatment Business (2020-2025)
11.15.5 Eli Lilly Recent Development
11.16 Sumitomo Dainippon Pharma
11.16.1 Sumitomo Dainippon Pharma Company Details
11.16.2 Sumitomo Dainippon Pharma Business Overview
11.16.3 Sumitomo Dainippon Pharma Night Blindness Treatment Introduction
11.16.4 Sumitomo Dainippon Pharma Revenue in Night Blindness Treatment Business (2020-2025)
11.16.5 Sumitomo Dainippon Pharma Recent Development
11.17 Leo Pharma
11.17.1 Leo Pharma Company Details
11.17.2 Leo Pharma Business Overview
11.17.3 Leo Pharma Night Blindness Treatment Introduction
11.17.4 Leo Pharma Revenue in Night Blindness Treatment Business (2020-2025)
11.17.5 Leo Pharma Recent Development
11.18 Bausch Health
11.18.1 Bausch Health Company Details
11.18.2 Bausch Health Business Overview
11.18.3 Bausch Health Night Blindness Treatment Introduction
11.18.4 Bausch Health Revenue in Night Blindness Treatment Business (2020-2025)
11.18.5 Bausch Health Recent Development
11.19 AstraZeneca
11.19.1 AstraZeneca Company Details
11.19.2 AstraZeneca Business Overview
11.19.3 AstraZeneca Night Blindness Treatment Introduction
11.19.4 AstraZeneca Revenue in Night Blindness Treatment Business (2020-2025)
11.19.5 AstraZeneca Recent Development
11.20 Cipla
11.20.1 Cipla Company Details
11.20.2 Cipla Business Overview
11.20.3 Cipla Night Blindness Treatment Introduction
11.20.4 Cipla Revenue in Night Blindness Treatment Business (2020-2025)
11.20.5 Cipla Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Merck
Pfizer Inc
GlaxoSmithKline PLC
Johnson & Johnson Private Limited
Roche Holding AG
Abbott
Mylan NV
Teva Pharmaceuticals
Sanofi
Novartis
Bayer
Sun Pharmaceutical Industries
Aurobindo Pharma
Lupin Pharma
Sumitomo Dainippon Pharma
LEO Pharma
Bausch Health
Astrazeneca plc
Cipla Ltd
Eli Lilly
List of Tables
 Table 1. Global Night Blindness Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Vitamin AD Drops
 Table 3. Key Players of Vitamin AD Softgels
 Table 4. Key Players of Vitamin A Capsule
 Table 5. Global Night Blindness Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Night Blindness Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Night Blindness Treatment Market Size by Region (2020-2025) & (US$ Million)
 Table 8. Global Night Blindness Treatment Market Share by Region (2020-2025)
 Table 9. Global Night Blindness Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 10. Global Night Blindness Treatment Market Share by Region (2026-2031)
 Table 11. Night Blindness Treatment Market Trends
 Table 12. Night Blindness Treatment Market Drivers
 Table 13. Night Blindness Treatment Market Challenges
 Table 14. Night Blindness Treatment Market Restraints
 Table 15. Global Night Blindness Treatment Revenue by Players (2020-2025) & (US$ Million)
 Table 16. Global Night Blindness Treatment Market Share by Players (2020-2025)
 Table 17. Global Top Night Blindness Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Night Blindness Treatment as of 2024)
 Table 18. Ranking of Global Top Night Blindness Treatment Companies by Revenue (US$ Million) in 2024
 Table 19. Global 5 Largest Players Market Share by Night Blindness Treatment Revenue (CR5 and HHI) & (2020-2025)
 Table 20. Global Key Players of Night Blindness Treatment, Headquarters and Area Served
 Table 21. Global Key Players of Night Blindness Treatment, Product and Application
 Table 22. Global Key Players of Night Blindness Treatment, Date of Enter into This Industry
 Table 23. Mergers & Acquisitions, Expansion Plans
 Table 24. Global Night Blindness Treatment Market Size by Type (2020-2025) & (US$ Million)
 Table 25. Global Night Blindness Treatment Revenue Market Share by Type (2020-2025)
 Table 26. Global Night Blindness Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 27. Global Night Blindness Treatment Revenue Market Share by Type (2026-2031)
 Table 28. Global Night Blindness Treatment Market Size by Application (2020-2025) & (US$ Million)
 Table 29. Global Night Blindness Treatment Revenue Market Share by Application (2020-2025)
 Table 30. Global Night Blindness Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 31. Global Night Blindness Treatment Revenue Market Share by Application (2026-2031)
 Table 32. North America Night Blindness Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 33. North America Night Blindness Treatment Market Size by Country (2020-2025) & (US$ Million)
 Table 34. North America Night Blindness Treatment Market Size by Country (2026-2031) & (US$ Million)
 Table 35. Europe Night Blindness Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 36. Europe Night Blindness Treatment Market Size by Country (2020-2025) & (US$ Million)
 Table 37. Europe Night Blindness Treatment Market Size by Country (2026-2031) & (US$ Million)
 Table 38. Asia-Pacific Night Blindness Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 39. Asia-Pacific Night Blindness Treatment Market Size by Region (2020-2025) & (US$ Million)
 Table 40. Asia-Pacific Night Blindness Treatment Market Size by Region (2026-2031) & (US$ Million)
 Table 41. Latin America Night Blindness Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 42. Latin America Night Blindness Treatment Market Size by Country (2020-2025) & (US$ Million)
 Table 43. Latin America Night Blindness Treatment Market Size by Country (2026-2031) & (US$ Million)
 Table 44. Middle East & Africa Night Blindness Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 45. Middle East & Africa Night Blindness Treatment Market Size by Country (2020-2025) & (US$ Million)
 Table 46. Middle East & Africa Night Blindness Treatment Market Size by Country (2026-2031) & (US$ Million)
 Table 47. Merck Company Details
 Table 48. Merck Business Overview
 Table 49. Merck Night Blindness Treatment Product
 Table 50. Merck Revenue in Night Blindness Treatment Business (2020-2025) & (US$ Million)
 Table 51. Merck Recent Development
 Table 52. Pfizer Company Details
 Table 53. Pfizer Business Overview
 Table 54. Pfizer Night Blindness Treatment Product
 Table 55. Pfizer Revenue in Night Blindness Treatment Business (2020-2025) & (US$ Million)
 Table 56. Pfizer Recent Development
 Table 57. GlaxoSmithKline Company Details
 Table 58. GlaxoSmithKline Business Overview
 Table 59. GlaxoSmithKline Night Blindness Treatment Product
 Table 60. GlaxoSmithKline Revenue in Night Blindness Treatment Business (2020-2025) & (US$ Million)
 Table 61. GlaxoSmithKline Recent Development
 Table 62. Johnson & Johnson Private Limited Company Details
 Table 63. Johnson & Johnson Private Limited Business Overview
 Table 64. Johnson & Johnson Private Limited Night Blindness Treatment Product
 Table 65. Johnson & Johnson Private Limited Revenue in Night Blindness Treatment Business (2020-2025) & (US$ Million)
 Table 66. Johnson & Johnson Private Limited Recent Development
 Table 67. Roche Holding AG Company Details
 Table 68. Roche Holding AG Business Overview
 Table 69. Roche Holding AG Night Blindness Treatment Product
 Table 70. Roche Holding AG Revenue in Night Blindness Treatment Business (2020-2025) & (US$ Million)
 Table 71. Roche Holding AG Recent Development
 Table 72. Abbott Company Details
 Table 73. Abbott Business Overview
 Table 74. Abbott Night Blindness Treatment Product
 Table 75. Abbott Revenue in Night Blindness Treatment Business (2020-2025) & (US$ Million)
 Table 76. Abbott Recent Development
 Table 77. Mylan Company Details
 Table 78. Mylan Business Overview
 Table 79. Mylan Night Blindness Treatment Product
 Table 80. Mylan Revenue in Night Blindness Treatment Business (2020-2025) & (US$ Million)
 Table 81. Mylan Recent Development
 Table 82. Teva Pharmaceuticals Company Details
 Table 83. Teva Pharmaceuticals Business Overview
 Table 84. Teva Pharmaceuticals Night Blindness Treatment Product
 Table 85. Teva Pharmaceuticals Revenue in Night Blindness Treatment Business (2020-2025) & (US$ Million)
 Table 86. Teva Pharmaceuticals Recent Development
 Table 87. Sanofi Company Details
 Table 88. Sanofi Business Overview
 Table 89. Sanofi Night Blindness Treatment Product
 Table 90. Sanofi Revenue in Night Blindness Treatment Business (2020-2025) & (US$ Million)
 Table 91. Sanofi Recent Development
 Table 92. Novartis Company Details
 Table 93. Novartis Business Overview
 Table 94. Novartis Night Blindness Treatment Product
 Table 95. Novartis Revenue in Night Blindness Treatment Business (2020-2025) & (US$ Million)
 Table 96. Novartis Recent Development
 Table 97. Bayer Company Details
 Table 98. Bayer Business Overview
 Table 99. Bayer Night Blindness Treatment Product
 Table 100. Bayer Revenue in Night Blindness Treatment Business (2020-2025) & (US$ Million)
 Table 101. Bayer Recent Development
 Table 102. Sun Pharmaceutical Industries Company Details
 Table 103. Sun Pharmaceutical Industries Business Overview
 Table 104. Sun Pharmaceutical Industries Night Blindness Treatment Product
 Table 105. Sun Pharmaceutical Industries Revenue in Night Blindness Treatment Business (2020-2025) & (US$ Million)
 Table 106. Sun Pharmaceutical Industries Recent Development
 Table 107. Aurobindo Pharma Company Details
 Table 108. Aurobindo Pharma Business Overview
 Table 109. Aurobindo Pharma Night Blindness Treatment Product
 Table 110. Aurobindo Pharma Revenue in Night Blindness Treatment Business (2020-2025) & (US$ Million)
 Table 111. Aurobindo Pharma Recent Development
 Table 112. Lupin pharma Company Details
 Table 113. Lupin pharma Business Overview
 Table 114. Lupin pharma Night Blindness Treatment Product
 Table 115. Lupin pharma Revenue in Night Blindness Treatment Business (2020-2025) & (US$ Million)
 Table 116. Lupin pharma Recent Development
 Table 117. Eli Lilly Company Details
 Table 118. Eli Lilly Business Overview
 Table 119. Eli Lilly Night Blindness Treatment Product
 Table 120. Eli Lilly Revenue in Night Blindness Treatment Business (2020-2025) & (US$ Million)
 Table 121. Eli Lilly Recent Development
 Table 122. Sumitomo Dainippon Pharma Company Details
 Table 123. Sumitomo Dainippon Pharma Business Overview
 Table 124. Sumitomo Dainippon Pharma Night Blindness Treatment Product
 Table 125. Sumitomo Dainippon Pharma Revenue in Night Blindness Treatment Business (2020-2025) & (US$ Million)
 Table 126. Sumitomo Dainippon Pharma Recent Development
 Table 127. Leo Pharma Company Details
 Table 128. Leo Pharma Business Overview
 Table 129. Leo Pharma Night Blindness Treatment Product
 Table 130. Leo Pharma Revenue in Night Blindness Treatment Business (2020-2025) & (US$ Million)
 Table 131. Leo Pharma Recent Development
 Table 132. Bausch Health Company Details
 Table 133. Bausch Health Business Overview
 Table 134. Bausch Health Night Blindness Treatment Product
 Table 135. Bausch Health Revenue in Night Blindness Treatment Business (2020-2025) & (US$ Million)
 Table 136. Bausch Health Recent Development
 Table 137. AstraZeneca Company Details
 Table 138. AstraZeneca Business Overview
 Table 139. AstraZeneca Night Blindness Treatment Product
 Table 140. AstraZeneca Revenue in Night Blindness Treatment Business (2020-2025) & (US$ Million)
 Table 141. AstraZeneca Recent Development
 Table 142. Cipla Company Details
 Table 143. Cipla Business Overview
 Table 144. Cipla Night Blindness Treatment Product
 Table 145. Cipla Revenue in Night Blindness Treatment Business (2020-2025) & (US$ Million)
 Table 146. Cipla Recent Development
 Table 147. Research Programs/Design for This Report
 Table 148. Key Data Information from Secondary Sources
 Table 149. Key Data Information from Primary Sources
 Table 150. Authors List of This Report


List of Figures
 Figure 1. Night Blindness Treatment Picture
 Figure 2. Global Night Blindness Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Night Blindness Treatment Market Share by Type: 2024 VS 2031
 Figure 4. Vitamin AD Drops Features
 Figure 5. Vitamin AD Softgels Features
 Figure 6. Vitamin A Capsule Features
 Figure 7. Global Night Blindness Treatment Market Size by Application (2020-2031) & (US$ Million)
 Figure 8. Global Night Blindness Treatment Market Share by Application: 2024 VS 2031
 Figure 9. Clinic Case Studies
 Figure 10. Hospital Case Studies
 Figure 11. Night Blindness Treatment Report Years Considered
 Figure 12. Global Night Blindness Treatment Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 13. Global Night Blindness Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Night Blindness Treatment Market Share by Region: 2024 VS 2031
 Figure 15. Global Night Blindness Treatment Market Share by Players in 2024
 Figure 16. Global Top Night Blindness Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Night Blindness Treatment as of 2024)
 Figure 17. The Top 10 and 5 Players Market Share by Night Blindness Treatment Revenue in 2024
 Figure 18. North America Night Blindness Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 19. North America Night Blindness Treatment Market Share by Country (2020-2031)
 Figure 20. United States Night Blindness Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. Canada Night Blindness Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Europe Night Blindness Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Night Blindness Treatment Market Share by Country (2020-2031)
 Figure 24. Germany Night Blindness Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. France Night Blindness Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. U.K. Night Blindness Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Italy Night Blindness Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Russia Night Blindness Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Nordic Countries Night Blindness Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Asia-Pacific Night Blindness Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Night Blindness Treatment Market Share by Region (2020-2031)
 Figure 32. China Night Blindness Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Japan Night Blindness Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. South Korea Night Blindness Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Southeast Asia Night Blindness Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. India Night Blindness Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Australia Night Blindness Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Latin America Night Blindness Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Night Blindness Treatment Market Share by Country (2020-2031)
 Figure 40. Mexico Night Blindness Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Brazil Night Blindness Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Middle East & Africa Night Blindness Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Night Blindness Treatment Market Share by Country (2020-2031)
 Figure 44. Turkey Night Blindness Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Saudi Arabia Night Blindness Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. UAE Night Blindness Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Merck Revenue Growth Rate in Night Blindness Treatment Business (2020-2025)
 Figure 48. Pfizer Revenue Growth Rate in Night Blindness Treatment Business (2020-2025)
 Figure 49. GlaxoSmithKline Revenue Growth Rate in Night Blindness Treatment Business (2020-2025)
 Figure 50. Johnson & Johnson Private Limited Revenue Growth Rate in Night Blindness Treatment Business (2020-2025)
 Figure 51. Roche Holding AG Revenue Growth Rate in Night Blindness Treatment Business (2020-2025)
 Figure 52. Abbott Revenue Growth Rate in Night Blindness Treatment Business (2020-2025)
 Figure 53. Mylan Revenue Growth Rate in Night Blindness Treatment Business (2020-2025)
 Figure 54. Teva Pharmaceuticals Revenue Growth Rate in Night Blindness Treatment Business (2020-2025)
 Figure 55. Sanofi Revenue Growth Rate in Night Blindness Treatment Business (2020-2025)
 Figure 56. Novartis Revenue Growth Rate in Night Blindness Treatment Business (2020-2025)
 Figure 57. Bayer Revenue Growth Rate in Night Blindness Treatment Business (2020-2025)
 Figure 58. Sun Pharmaceutical Industries Revenue Growth Rate in Night Blindness Treatment Business (2020-2025)
 Figure 59. Aurobindo Pharma Revenue Growth Rate in Night Blindness Treatment Business (2020-2025)
 Figure 60. Lupin pharma Revenue Growth Rate in Night Blindness Treatment Business (2020-2025)
 Figure 61. Eli Lilly Revenue Growth Rate in Night Blindness Treatment Business (2020-2025)
 Figure 62. Sumitomo Dainippon Pharma Revenue Growth Rate in Night Blindness Treatment Business (2020-2025)
 Figure 63. Leo Pharma Revenue Growth Rate in Night Blindness Treatment Business (2020-2025)
 Figure 64. Bausch Health Revenue Growth Rate in Night Blindness Treatment Business (2020-2025)
 Figure 65. AstraZeneca Revenue Growth Rate in Night Blindness Treatment Business (2020-2025)
 Figure 66. Cipla Revenue Growth Rate in Night Blindness Treatment Business (2020-2025)
 Figure 67. Bottom-up and Top-down Approaches for This Report
 Figure 68. Data Triangulation
 Figure 69. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

Global Night Vision Glasses Market Insights Forecast to 2030
Night Vision Driving Glasses Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Optic Neuropathy Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Night Vision Filters Market Insights Forecast to 2030
Global Visual Impairment Market Research Report 2024
Global Cone rod Dystrophy Treatment Market Research Report 2025
Global Night Vision Optical Systems Market Research Report 2024
Global Light Therapy Glasses Market Insights Forecast to 2030
Myopia and Presbyopia Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Uveitis Treatment Market Research Report 2024
Global Ophthalmology Disorders Drug Market Insights Forecast to 2030
Global Low Vision Glasses Market Research Report 2024
Global Seasonal Affective Disorder Light Therapy Market Research Report 2024
Global Low Vision Aids Market Insights Forecast to 2030
Global Low Vision Electronic Visual Aids Market Insights Forecast to 2030
Amblyopia Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Inflammatory Eye Diseases Treatment Market Research Report 2025
Global Myopia Glasses Market Insights Forecast to 2030
Global Night Vision Equipment Market Research Report 2024
Global Retinal Disorders Treatment Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions